Retrieving the latest stories.
The most consequential developments in technology and the world, selected against strict editorial criteria. Each is explained in twenty seconds.
Why it mattersA randomized trial found that 50 expert analysts followed an AI agent's hidden, coin-flip-assigned lean 86% of the time, repeated its arguments, and rarely credited it, which undermines the assumption that human sign-off means independent judgment, though the…
Why it mattersCourt discovery records show 62 HSI agents, 11 undercover operatives, Reaper drones, 15TB of infiltrated Signal chats, Patriot Act financial queries and data-broker fusion used against anti-ICE activists, revealing how post-9/11 surveillance tools are being t…
Why it matters2B IPO and 21% debut are widely covered, but the story is mainly deal and market mechanics, with limited evidence of a concrete shift in access, power, or infrastructure for ordinary people.
Why it mattersA federal agency suing a state to preempt its gambling ban on Kalshi, amid split appeals rulings, shows the unsettled fight over who regulates prediction markets, though this is an incremental step in an ongoing legal contest.
Why it mattersNvidia ($3B) and AMD ($1B) buying into Meta's $95B raise shows chip suppliers financing their own biggest customers, a circular-capital pattern in AI infrastructure, though this item is mostly deal mechanics.
Why it mattersSK Hynix's record results, with long-term contracts covering over half of 2027-28 capacity and demand exceeding supply through 2030, show memory becoming the scarce chokepoint of AI buildout, though the story is still mostly an earnings and shareholder-return…
Why it mattersSharing is on by default for most users, including in the US, and opt-out works only on desktop and web.
Why it mattersA draft Delaware bill would create a legal entity run by an AI agent with its human owner shielded from liability, and a congressional probe now frames a state-versus-federal fight over AI corporate law.
Why it mattersAnthropic's disclosed pilots show AI agents taking over design, manufacturing-record review, regulatory drafting and whole-company operations in drug development, which could reshape how biotechs are staffed and funded, though results are preclinical and self…
Why it mattersOracle will also run other non-Nvidia chips and denies shifting away from Nvidia, which tempers the diversification reading of the story.